Ispecimen Inc. current report, 17 February 2022

Full document

Business Context and Reporting Period

Company: iSpecimen Inc. (ISPC)
Filing Type: Form 8-K (Current Report)
Date of Report: February 17, 2022
Reporting Period: Fiscal Year ended December 31, 2021 (and Q4 2021)
Context: The filing announces the issuance of a press release containing preliminary unaudited financial results for the fiscal year ended December 31, 2021. The company is classified as an emerging growth company.

Key Financial Metrics

Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained in the attached "Earnings Release" (Exhibit 99.1) and "Investor Presentation" (Exhibit 99.2), which are not included in the source text.

Material Changes

Comparison to Prior Period: The filing text does not provide specific data to compare current results against prior periods. It notes that the financial information is based on preliminary unaudited statements and may be subject to change before the filing of the audited 2021 Annual Report on Form 10-K.

Guidance, Outlook, and Risks

  • Forward-Looking Statements: The filing contains forward-looking statements regarding future expectations, which are subject to risks and uncertainties.
  • Key Risks Identified:
    • Lack of profitability.
    • Continued capital needs.
    • Lack of a long operating history.
    • Growth strategy execution.
    • Impact of the COVID-19 pandemic.
    • Technology development plans.
    • Regulatory environment.
  • Future Filings: The company expects to file audited financial statements for the fiscal year ended December 31, 2021, on or before March 31, 2022.

Investor Verification Checklist

  • Verify the specific revenue and net loss figures in the attached Press Release (Exhibit 99.1) and Investor Presentation (Exhibit 99.2).
  • Confirm the company's cash position and burn rate to assess runway given the noted "continued capital needs."
  • Review the upcoming Form 10-K (due by March 31, 2022) for audited figures to reconcile with these preliminary unaudited results.
  • Assess the specific impact of the COVID-19 pandemic on the company's operations as detailed in the full risk factor disclosures.